Otolith Sound Inc
Washington, DC · Founded 2015 · CIK 0001677664 · Medtech · Private
Wearable medical device for noninvasive treatment of chronic vertigo
otolithlabs.com →- Grants
- $1.6M
- 3 awards
- Sector median: 1
- Raised
- $31M
- 5 Form D · Oct 2024
- 23 months since last filing
- Contracts
- $248K
- 1 award · Defense
- #439 of 4531 in medtech
- Patents
- 17
- 5 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $25,000 | |
| Private capital raised | Form D · SEC | $405,000 | |
| Private capital raised | Form D · SEC | $750,000 | |
| Federal grant | Department of Defense · Phase II · Direct to Phase II Open Topic: Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need | $1,489,957 | |
| Federal contract | Department of Defense · Medical R&d Purchase Order For Dha SBIR Ph I Proposal No. SBIR Ph I H192-002-0069 For Treatment Of Vestibular Impairment Of Service Members After Traumatic Brain Injury Through Use Of An Individualized, Portable Neuromodulation Device | $247,874 | |
| Federal grant | Department of Defense · Phase I · Integration of nVSM Motion Sickness Mitigating Technology to Improve Mission Readiness | $49,999 | |
| Federal grant | Department of Defense · Phase I · Integration of nVSM Motion Sickness Mitigating Technology to Improve Mission Readiness | $49,999 | |
| Private capital raised | Form D · SEC | $24,799,853 | |
| Private capital raised | Form D · SEC | $4,899,055 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 436 | TYMPANOGEN, INC. | $250K | $2.2M |
| 437 | Akrotome Imaging, INC | $250K | — |
| 438 | Specific Diagnostics, Inc. | $249K | $17M |
| 439 | Otolith Sound Inc | $248K | $31M |
| 440 | INSTADIAGNOSTICS INC | $244K | — |
| 441 | InnoTech Precision Medicine, Inc | $244K | — |
| 442 | Unlimited Tomorrow, Inc. | $237K | $6.7M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Anthony AiudiDirector
- Jon AkersExecutive Officer
- John DaggittExecutive Officer
- Didier DepireuxExecutive Officer
- Kevin FranckExecutive Officer
- Thomas HardartExecutive Officer
- Tom HardartExecutive Officer
- Raphael MichelDirector
- Samuel OwenDirector · Executive Officer
- Dan WagnerExecutive Officer
Patents
- Systems, Devices, And Methods For Treating Vestibular Conditionsgranted
- Device For Mitigating Motion Sickness And Other Responses To Inconsistent Sensory Informationapplication
- Device For Mitigating Motion Sickness And Other Responses To Inconsistent Sensory Informationgranted
- Systems, Devices, And Methods For Treating Vestibular Conditionsgranted
- Systems, Devices, And Methods For Treating Vestibular Conditionsgranted
- Systems, Devices, And Methods For Treating Vestibular Conditionsgranted
- Device For Mitigating Motion Sickness And Other Responses To Inconsistent Sensory Informationapplication
- Devices And Methods For Reducing The Symptoms Of Maladies Of The Vestibular Systemapplication
- Device For Mitigating Motion Sickness And Other Responses To Inconsistent Sensory Informationapplication
- Systems, Devices, And Methods For Treating Vestibular Conditionsapplication
- Systems, Devices, And Methods For Modulating A Velocity Storage Mechanisms To Treat Vestibular Conditionsapplication
- Systems, Devices, And Methods For Treating Vestibular Conditionsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.